JP2018528210A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018528210A5 JP2018528210A5 JP2018511277A JP2018511277A JP2018528210A5 JP 2018528210 A5 JP2018528210 A5 JP 2018528210A5 JP 2018511277 A JP2018511277 A JP 2018511277A JP 2018511277 A JP2018511277 A JP 2018511277A JP 2018528210 A5 JP2018528210 A5 JP 2018528210A5
- Authority
- JP
- Japan
- Prior art keywords
- body weight
- seq
- pharmaceutical composition
- antibody
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562214449P | 2015-09-04 | 2015-09-04 | |
| US62/214,449 | 2015-09-04 | ||
| US201562259061P | 2015-11-24 | 2015-11-24 | |
| US62/259,061 | 2015-11-24 | ||
| PCT/US2016/050183 WO2017040986A1 (en) | 2015-09-04 | 2016-09-02 | Methods for treating heart failure using glucagon receptor antagonistic antibodies |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2018528210A JP2018528210A (ja) | 2018-09-27 |
| JP2018528210A5 true JP2018528210A5 (cg-RX-API-DMAC7.html) | 2019-11-28 |
| JP6890340B2 JP6890340B2 (ja) | 2021-06-18 |
| JP6890340B6 JP6890340B6 (ja) | 2021-07-14 |
Family
ID=58188491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018511277A Active JP6890340B6 (ja) | 2015-09-04 | 2016-09-02 | グルカゴン受容体アンタゴニスト抗体を用いた心不全の治療法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10765737B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3344279B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6890340B6 (cg-RX-API-DMAC7.html) |
| CN (1) | CN108348582B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016318097B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2999747A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017040986A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7005638B2 (ja) | 2017-01-27 | 2022-02-04 | エヌジーエム バイオファーマシューティカルス,インコーポレーテッド | グルカゴン受容体結合タンパク質及びその使用方法 |
| EP3829636A1 (en) | 2018-07-27 | 2021-06-09 | NGM Biopharmaceuticals, Inc. | Use of glucagon receptor antagonists with immunotherapeutic agent |
| JP7840511B2 (ja) | 2019-02-01 | 2026-04-06 | 石▲薬▼集▲団▼巨石生物制▲薬▼有限公司 | 抗クローディン18抗体及びそれらの使用の方法 |
| CN118393150B (zh) * | 2024-06-27 | 2024-09-13 | 潍坊市润生畜禽良种有限公司 | 一种优化gcgr卵黄抗体制备的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030103983A1 (en) | 2002-05-09 | 2003-06-05 | Pressler Milton Lethan | Ace inhibitor-vasopressin antagonist combinations |
| WO2006005469A2 (en) | 2004-07-15 | 2006-01-19 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with glucagon receptor (gcgr) |
| CL2007002668A1 (es) * | 2006-09-20 | 2008-05-09 | Amgen Inc | Proteina de union a antigeno que se une al receptor de glucagon humano; acido nucleico que la codifica; metodo de produccion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir la diabetes tipo 2. |
| US9034883B2 (en) * | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
| US8771696B2 (en) | 2010-11-23 | 2014-07-08 | Regeneron Pharmaceuticals, Inc. | Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor |
-
2016
- 2016-09-02 CA CA2999747A patent/CA2999747A1/en active Pending
- 2016-09-02 WO PCT/US2016/050183 patent/WO2017040986A1/en not_active Ceased
- 2016-09-02 AU AU2016318097A patent/AU2016318097B2/en not_active Ceased
- 2016-09-02 EP EP16843103.9A patent/EP3344279B1/en active Active
- 2016-09-02 JP JP2018511277A patent/JP6890340B6/ja active Active
- 2016-09-02 CN CN201680061804.XA patent/CN108348582B/zh active Active
- 2016-09-02 US US15/757,352 patent/US10765737B2/en active Active
-
2020
- 2020-07-28 US US16/941,290 patent/US11446376B2/en active Active